Search by
Industry
Department

Industry Update: Vigilance for Medical Devices

After a few quiet years, several important European regulatory changes have occurred that will affect most medical device manufacturers. Most notably, Competent Authorities are now expecting manufacturers to have a good understanding of post-market surveillance, including vigilance. Notified Bodies and Competent Authorities alike are starting to make this a key element of their inspections and companies must be prepared.


In this presentation, Dr. Loh discusses important new revisions to MEDDEV 2.12-1 rev 5, Guidelines on a medical devices vigilance system, published in April 2007. The guidelines entered into force on January 1st, 2008.


This audio conference covers:


  • Differences between revision 4 (2001) and revision 5 (2007)
  • Adverse event reporting requirements
  • Field safety corrective actions
  • New items: periodic summary reporting and trend reporting
  • New "event" reporting requirements
  • What constitutes "user error" and "abnormal use"


About the speaker:


Dr. Evangeline Loh oversees regulatory consulting support for Emergo clients worldwide, and oversees Emergo's 400 plus Authorized Representative clients. Prior to joining Emergo Group, Dr. Loh was involved in regulatory affairs for the surgery and critical care units of Cook, Inc. She has extensive knowledge of US and EU regulations, in addition to working on regulatory submissions around the world. Prior to her tenure at Cook, Dr. Loh worked for the Division of Biomedical Sciences at the Association of American Medical Colleges (AAMC) in Washington, DC. Her role there was to develop data metrics and quality control measures, conduct statistical analysis to evaluate the performance of clinical sites, and to manage graduate education policy.


As a graduate student at the University of Texas Health Science Center at San Antonio, Dr. Loh designed and implemented research protocols to conduct experimental research using complex molecular techniques. She obtained a BS in Microbiology from Cornell University, a PhD in Pharmacology from the University of Texas Health Science Center at San Antonio, and holds the RAC (US, EU) designation from the Regulatory Affairs Professional Society.


Who should attend?


  • Senior Management
  • Regulatory Affairs
  • Quality Assurance
  • Sales and Marketing


This audio conference is rated General Interest.


Speaker & Time

Dr. Evangeline Loh, Emergo Group Inc.
Industry Update: Vigilance for Medical Devices
Title: Director of Regulatory Affairs
Duration: 60 minutes
Discount: Buy 2 items, get 25% off your order using coupon code FX25%OFF
Event Type: Previously recorded on 2008-01-17
Item #: ac20080708
17 Jan 2008 
Registration Price:
$249.00

Order Info

Select Order Type:  
Include Transcript With Order?:  
Quantity
More
Less
 
 
Bookmark and Share reviews

Reviews

Average Rating: (based on 8 reviews)

Showing 1 to 4 of 8 Reviews:

by A.D.
Medical Supervisor
It was very good.
by B.M.
Quality Compliance
Not sure if you do this every time, but referencing the slide number when changing slides was critical to me as the one responsible for managing the slide deck.
by Y.M.
Engineer
Improve audio quality
by T.R.
Product Safety Engineer
Ensure adequate connection strength and microphone placement for the speaker. At times it was slightly hard to hear but overall a job well done.
12
Rate this item
Similar Events
More about Monitoring Essentials for International Medical Device Trials


The New MDD: 14 Things You Need to Know
Dr. Evangeline Loh, Emergo Group Inc.
More about The New MDD: 14 Things You Need to Know


Understanding the Principles and Pitfalls of 510k Submissions
Rebecca Pine, Eisner Safety Consultants
More about Understanding the Principles and Pitfalls of 510k Submissions

 
Recently Viewed
More about Harnessing the Marketing Potential of Social Networking Sites


More about Clinical Trial Insurance: Managing Common Problems and Pitfalls


Developing a Post-Approval Labeling Risk Management Strategy
Gary Gamerman, Seraphim Life Sciences Consulting LLC
More about Developing a Post-Approval Labeling Risk Management Strategy


Adaptive Trial Design: Streamlining the Clinical Supply Process
Geert Langendries, Covance IVRS Project Management Group
More about Adaptive Trial Design: Streamlining the Clinical Supply Process


More about Ensuring GCP-Compliant Trials with Clinical Quality Audits

© Copyright 2010
ForeignExchange Translations.
All rights reserved.

Home  |   FAQ  |   Blog  |   Translation Services  |   Search  |   Privacy Policy  |   Terms of Use  |   Contact Us